TLC-3595

· OrsoBio, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLC-3595, covering 2024-08-20 to 2024-08-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating Daily Oral Doses of TLC-3595 in Participants With Insulin Resistance [Phase 2]